Adult-Onset Still’s Disease in a 28-Year-Old Man From Ghana
Open Access
- 20 September 2021
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 13 (9)
Abstract
Adult-onset Still’s disease is a rare, autoinflammatory disease characterized by spiking fevers, arthritis, salmon-colored skin rash, and leukocytosis. It has been compared to systemic juvenile idiopathic arthritis because of its similar features but is much rarer than its pediatric counterpart. It is usually treated with corticosteroids and disease-modifying anti-rheumatic drugs. However, those with refractory disease are candidates for one of many biological therapies. We present the case of a 28-year-old man who was successfully managed with first-line steroid therapy.Keywords
This publication has 10 references indexed in Scilit:
- Adult-onset still's disease and treatment results with tocilizumabInternational Journal Of Clinical Practice, 2021
- Neurological manifestations of adult-onset Still's disease-case-based reviewClinical Rheumatology, 2021
- Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trialAnnals of the Rheumatic Diseases, 2020
- Tofacitinib in refractory adult-onset Still's disease: 14 cases from a single centre in ChinaAnnals of the Rheumatic Diseases, 2020
- Adult-onset Still's Disease: A Case ReportJournal of Nepal Medical Association, 2020
- Pathogenesis, disease course, and prognosis of adult-onset Still's disease: an update and reviewChinese Medical Journal, 2019
- A comprehensive review on adult onset Still's diseaseJournal of Autoimmunity, 2018
- Pathogenesis of adult-onset Still’s disease: new insights from the juvenile counterpartImmunologic Research, 2014
- Preliminary criteria for classification of adult Still's disease.1992
- Still's disease in the adult.Annals of the Rheumatic Diseases, 1971